Kidney disease can be slowed significantly, and in early stages, further damage can sometimes be halted almost entirely. But in most cases, kidney tissue that has already been lost does not regenerate. The realistic goal, and the one that keeps people off dialysis, is stopping the decline from getting worse. How successfully you can do that depends on the stage of disease, what’s causing it, and how aggressively the key risk factors are managed.
Slowing vs. Reversing: What’s Actually Possible
Chronic kidney disease is staged by a blood test called eGFR, which estimates how well your kidneys filter waste. The stages break down like this:
- Stage 1: eGFR above 90 (normal filtering, but signs of damage like protein in urine)
- Stage 2: eGFR 60 to 89
- Stage 3A: eGFR 45 to 59
- Stage 3B: eGFR 30 to 44
- Stage 4: eGFR 15 to 29
- Stage 5: eGFR below 15 (kidney failure)
In stages 1 and 2, the kidneys still have substantial function. If the underlying cause is identified and treated early, some people stabilize and stay stable for years or even decades. Roughly 30% of patients in one long-term study maintained stable kidney function well beyond the point where decline would typically begin. That’s not reversal in the sense of regrowing tissue, but it’s functionally the same as stopping the disease in its tracks.
Once kidney function drops below a critical threshold, though, the disease tends to progress on its own momentum regardless of the original cause. That’s why early detection matters so much. By stage 4 or 5, the focus shifts from stopping progression to slowing it enough to delay or avoid dialysis.
Blood Pressure: The Single Biggest Lever
High blood pressure damages the tiny blood vessels inside the kidneys, and it’s both a cause and a consequence of kidney disease. Controlling it is the most impactful thing you can do at any stage. The current KDIGO guidelines recommend a systolic blood pressure target below 120 mmHg for adults with CKD and high blood pressure, measured under standardized conditions. That’s lower than the general population target, and it reflects how sensitive damaged kidneys are to even mildly elevated pressure.
Reaching this target usually requires medication, often a type that blocks the renin-angiotensin system. These drugs do double duty: they lower blood pressure and they reduce the amount of protein leaking through the kidneys, which is itself a major driver of further damage. Reducing protein in the urine as much as possible, ideally to very low levels, is associated with the strongest long-term protection.
Blood Sugar Control for Diabetic Kidney Disease
Diabetes is the leading cause of kidney disease worldwide, and keeping blood sugar in range is essential for slowing it. The American Diabetes Association recommends an A1C below 7.0% for most adults with diabetes. For people who already have diabetic kidney disease, KDIGO guidelines suggest an individualized A1C target between 6.5% and 8.0%, depending on disease stage, other health conditions, life expectancy, and the risk of dangerously low blood sugar episodes.
The key word there is individualized. Pushing A1C very low can backfire if it causes frequent low blood sugar, which carries its own risks. The sweet spot is tight enough control to protect the kidneys without creating new problems.
Medications That Slow Progression
A newer class of drugs originally developed for diabetes has become a cornerstone of kidney protection. These medications, called SGLT2 inhibitors, reduce the risk of kidney disease progression by roughly 38% to 40% across a wide range of patients. That benefit holds whether or not someone has diabetes. In people without diabetes, the drugs cut progression risk by about 30%, and in those with diabetes, by about 40%.
What’s striking is how consistent the benefit is across different levels of kidney function. Even in stage 4 disease, where the kidneys are already severely impaired, SGLT2 inhibitors significantly slowed the rate of further decline. Across all groups studied, these drugs cut the annual rate of kidney function loss roughly in half. Combined with blood pressure medications that reduce protein leakage, they represent the most effective drug combination currently available for preserving remaining kidney function.
Protein in Your Urine: A Warning and a Target
The amount of protein leaking into your urine, measured as the urine albumin-to-creatinine ratio (UACR), is one of the strongest predictors of how fast kidney disease will progress. A UACR above 300 mg/g signals seriously increased risk. A UACR above 700 mg/g indicates severe kidney damage and is the threshold where guidelines recommend immediate nephrology referral and intensified treatment without waiting for a repeat test.
Reducing proteinuria isn’t just a lab number to watch. It’s a treatment target. The more protein leakage can be reduced through blood pressure control, SGLT2 inhibitors, and dietary changes, the more the kidneys are protected from ongoing scarring. This is why monitoring urine protein is just as important as tracking eGFR.
Dietary Changes That Protect the Kidneys
Two dietary adjustments have the strongest evidence behind them: limiting sodium and moderating protein intake.
The National Kidney Foundation recommends no more than 2,400 mg of sodium per day for people with CKD who aren’t on dialysis. For context, the average American consumes around 3,400 mg daily, so most people need to cut roughly a third. Sodium drives fluid retention and raises blood pressure, both of which accelerate kidney damage. For people on hemodialysis, the target drops further to 2,000 mg per day.
Protein is more nuanced. Eating large amounts of protein forces the kidneys to work harder, increasing pressure inside the filtering units. For people with stages 3 through 5 CKD, guidelines recommend a low-protein diet of about 0.55 to 0.60 grams of protein per kilogram of body weight per day. For a 170-pound person, that works out to roughly 42 to 46 grams of protein daily, considerably less than the 70 to 100 grams many people eat. The KDIGO guidelines are slightly more lenient, suggesting 0.8 grams per kilogram for people with an eGFR below 30. Either way, the shift typically means eating less meat and relying more on plant-based protein sources, ideally with guidance from a dietitian familiar with kidney disease.
Medications and Supplements to Avoid
Some common over-the-counter drugs are genuinely dangerous for kidneys that are already compromised. Non-steroidal anti-inflammatory drugs like ibuprofen and naproxen top the list. They constrict blood vessels inside the kidneys, reducing blood flow and causing direct tissue damage. A single course may not matter for someone with healthy kidneys, but for someone with CKD, regular use can trigger a sharp, sometimes irreversible drop in function.
The risk multiplies with certain drug combinations. Taking an anti-inflammatory along with a blood pressure medication and a diuretic, a pattern sometimes called the “triple whammy,” significantly raises the chance of acute kidney injury. If you have CKD, acetaminophen is generally the safer choice for pain, and any new medication or supplement should be checked for kidney safety first. Many herbal supplements are not tested for kidney effects and some contain ingredients that are directly toxic to renal tissue.
What “Stopping” Kidney Disease Looks Like in Practice
For most people, stopping kidney disease doesn’t mean a single dramatic intervention. It means stacking several modest protections on top of each other: getting blood pressure consistently below 120 systolic, keeping blood sugar controlled if diabetic, taking kidney-protective medications, reducing sodium and protein in the diet, avoiding drugs that harm the kidneys, and monitoring urine protein levels so treatment can be adjusted before damage accelerates.
Each of these individually provides a measurable benefit. Together, they can reduce the rate of kidney function loss by well over half. For someone diagnosed at stage 2 or early stage 3, that combination can mean the difference between decades of stable function and progressing to dialysis within 10 to 15 years. Even at stage 4, aggressive management buys meaningful time and quality of life. The earlier these strategies start, the more kidney function there is left to protect.